Timothy Nduhukire, Ismail Abiola Adebayo, Rachel Luwaga, Immaculate Mandela, Agnes Napyo, Herbert Ainamani, Victor Musiime
{"title":"Missed Appointments and Associated Factors Among Children Accessing Anti-Retroviral Therapy During the COVID-19 Pandemic in South Western Uganda.","authors":"Timothy Nduhukire, Ismail Abiola Adebayo, Rachel Luwaga, Immaculate Mandela, Agnes Napyo, Herbert Ainamani, Victor Musiime","doi":"10.2147/HIV.S520964","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Disruptions to the health sector in Uganda during the COVID 19 pandemic affected health services in the early phases of the pandemic. Not much data exists on their effect on these same services during the later stages of the pandemic especially for children. To fill this gap, we set out to study missed appointments and their associated factors during the lockdown for children receiving Anti-Retroviral Therapy (ART).</p><p><strong>Methods: </strong>This was a retrospective cohort study from January 2022 to May 2022. We included all children aged 0-15 and adolescents aged 15-19 years who were on ART. Electronic Medical Records (EMR) for the participants in the last 12 months were extracted. Descriptive statistics are presented. Binary logistic regression was performed, and odds ratios were reported.</p><p><strong>Results: </strong>Out of the 382 participants, 26 (6.8%) missed appointments during the study period. The likelihood of missing appointments was increased when drugs were given to last 4 months than when they were given to last one month (COR 3.207, P value 0.026, 95% CI 1.150-8.943). Patients were also more likely to miss appointments if their mode of receiving drugs was Facility based group (COR 3.174, P = 0.043, 95% CI 1.037-9.713). Not having a viral load in the last 12 months increased the likelihood of missing an appointment (COR 2.309, P = 0.049, CI 1.004-5.306).</p><p><strong>Conclusion: </strong>A drug refill of 4 months and being scheduled to receive drugs by Facility-based group model predisposed the participants to missing the next appointment. Home- or community-based ART delivery to clients as well as drug prescriptions for a longer period could reduce missed appointments. Timely viral load testing should be encouraged as it correlates with adherence to appointments. More research is needed on the safety, storage practices and efficacy of ART given to last more than 2 months.</p>","PeriodicalId":46555,"journal":{"name":"HIV AIDS-Research and Palliative Care","volume":"17 ","pages":"175-184"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12219174/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV AIDS-Research and Palliative Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/HIV.S520964","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Disruptions to the health sector in Uganda during the COVID 19 pandemic affected health services in the early phases of the pandemic. Not much data exists on their effect on these same services during the later stages of the pandemic especially for children. To fill this gap, we set out to study missed appointments and their associated factors during the lockdown for children receiving Anti-Retroviral Therapy (ART).
Methods: This was a retrospective cohort study from January 2022 to May 2022. We included all children aged 0-15 and adolescents aged 15-19 years who were on ART. Electronic Medical Records (EMR) for the participants in the last 12 months were extracted. Descriptive statistics are presented. Binary logistic regression was performed, and odds ratios were reported.
Results: Out of the 382 participants, 26 (6.8%) missed appointments during the study period. The likelihood of missing appointments was increased when drugs were given to last 4 months than when they were given to last one month (COR 3.207, P value 0.026, 95% CI 1.150-8.943). Patients were also more likely to miss appointments if their mode of receiving drugs was Facility based group (COR 3.174, P = 0.043, 95% CI 1.037-9.713). Not having a viral load in the last 12 months increased the likelihood of missing an appointment (COR 2.309, P = 0.049, CI 1.004-5.306).
Conclusion: A drug refill of 4 months and being scheduled to receive drugs by Facility-based group model predisposed the participants to missing the next appointment. Home- or community-based ART delivery to clients as well as drug prescriptions for a longer period could reduce missed appointments. Timely viral load testing should be encouraged as it correlates with adherence to appointments. More research is needed on the safety, storage practices and efficacy of ART given to last more than 2 months.
背景:在2019冠状病毒病大流行期间,乌干达卫生部门的中断影响了大流行早期阶段的卫生服务。在大流行的后期阶段,特别是对儿童而言,它们对这些相同服务的影响的数据并不多。为了填补这一空白,我们开始研究在封锁期间接受抗逆转录病毒治疗(ART)的儿童错过预约及其相关因素。方法:这是一项回顾性队列研究,时间为2022年1月至2022年5月。我们纳入了所有接受抗逆转录病毒治疗的0-15岁儿童和15-19岁青少年。提取了参与者最近12个月的电子医疗记录(EMR)。给出了描述性统计。进行二元逻辑回归,并报告比值比。结果:在382名参与者中,26名(6.8%)在研究期间错过了预约。用药时间为4个月的患者错过预约的可能性高于用药时间为1个月的患者(COR 3.207, P值0.026,95% CI 1.150 ~ 8.943)。如果患者接受药物的方式为设施基础组,患者也更容易错过预约(COR 3.174, P = 0.043, 95% CI 1.037 ~ 9.713)。在过去12个月内没有病毒载量增加了错过预约的可能性(COR 2.309, P = 0.049, CI 1.004-5.306)。结论:以医院为基础的分组模式安排4个月的药物补充和药物分配,使参与者容易错过下一次预约。向客户提供家庭或社区抗逆转录病毒治疗以及较长时间的药物处方可以减少错过的预约。应鼓励及时的病毒载量检测,因为它与遵守预约有关。需要对持续2个月以上的抗逆转录病毒治疗的安全性、储存方法和疗效进行更多的研究。
期刊介绍:
About Dove Medical Press Dove Medical Press Ltd is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC. We specialize in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine. Dove Medical Press was founded in 2003 with the objective of combining the highest editorial standards with the ''best of breed'' new publishing technologies. We have offices in Manchester and London in the United Kingdom, representatives in Princeton, New Jersey in the United States, and our editorial offices are in Auckland, New Zealand. Dr Scott Fraser is our Medical Director based in the UK. He has been in full time clinical practice for over 20 years as well as having an active research interest.